Introduction

Parameters of the Report
This report, which contains the complete list of recommendations with pertinent references, is Part II of Guidelines for Environmental Infection Control in Health-Care Facilities. The full four-part guidelines will be available on CDC's Division of Healthcare Quality Promotion (DHQP) website. Relative to previous CDC guidelines, this report
• revises multiple sections (e.g., cleaning and disinfection of environmental surfaces, environmental sampling, laundry and bedding, and regulated medical waste) from previous editions of CDC's Guideline for Handwashing and Hospital Environmental Control; • incorporates discussions of air and water environmental concerns from CDC's Guideline for Prevention of Nosocomial Pneumonia; • consolidates relevant environmental infection-control measures from other CDC guidelines; and • includes two topics not addressed in previous CDC guidelines -infection-control concerns related to animals in health-care facilities and water quality in hemodialysis settings.
In the full guidelines, Part I, Background Information: Environmental Infection Control in Health-Care Facilities, provides a comprehensive review of the relevant scientific literature. Attention is given to engineering and infectioncontrol concerns during construction, demolition, renovation, and repair of health-care facilities. Use of an infection-control risk assessment is strongly supported before the start of these or any other activities expected to generate dust or water aerosols. Also reviewed in Part I are infection-control measures used to recover from catastrophic events (e.g., flooding, sewage spills, loss of electricity and ventilation, or disruption of water supply) and the limited effects of environmental surfaces, laundry, plants, animals, medical wastes, cloth furnishings, and carpeting on disease transmission in health-care facilities. Part III and Part IV of the full guidelines provide references (for the complete guideline) and appendices, respectively.
Part II (this report) contains recommendations for environmental infection control in health-care facilities, describing control measures for preventing infections associated with air, water, or other elements of the environment. These recommendations represent the views of different divisions within CDC's National Center for Infectious Diseases and the Healthcare Infection Control Practices Advisory Committee (HICPAC), a 12-member group that advises CDC on concerns related to the surveillance, prevention, and control of health-care-associated infections, primarily in U.S. health-care facilities. In 1999, HICPAC's infection-control focus was expanded from acute-care hospitals to all venues where health care is provided (e.g., outpatient surgical centers, urgent care centers, clinics, outpatient dialysis centers, physicians' offices, and skilled nursing facilities). The topics addressed in this report are applicable to the majority of health-care facilities in the United States. This report is intended for use primarily by infection-control practitioners, epidemiologists, employee health and safety personnel, engineers, facility managers, information systems professionals, administrators, environmental service professionals, and architects. Key recommendations include
• infection-control impact of ventilation system and water system performance; • establishment of a multidisciplinary team to conduct infection-control risk assessment; • use of dust-control procedures and barriers during construction, repair, renovation, or demolition; • environmental infection-control measures for special areas with patients at high risk; • use of airborne-particle sampling to monitor the effectiveness of air filtration and dust-control measures;
• procedures to prevent airborne contamination in operating rooms when infectious tuberculosis (TB) patients require surgery; • guidance regarding appropriate indications for routine culturing of water as part of a comprehensive control program for legionellae; • guidance for recovering from water-system disruptions, water leaks, and natural disasters (e.g., flooding); • infection-control concepts for equipment using water from main lines (e.g., water systems for hemodialysis, ice machines, hydrotherapy equipment, dental unit water lines, and automated endoscope reprocessors); • environmental surface cleaning and disinfection strategies with respect to antibiotic-resistant microorganisms; • infection-control procedures for health-care laundry;
• use of animals in health care for activities and therapy;
• managing the presence of service animals in health-care facilities; • infection-control strategies for when animals receive treatment in human health-care facilities; and • a call to reinstate the practice of inactivating amplified cultures and stocks of microorganisms onsite during medical waste treatment. Topics outside the scope of this report include 1) noninfectious adverse events (e.g., sick building syndrome), 2) environmental concerns in the home, 3) home health care, 4) terrorism, and 5) health-care-associated foodborne illness.
Wherever possible, the recommendations in this report are based on data from well-designed scientific studies. However, certain of these studies were conducted by using narrowly defined patient populations or specific health-care settings (e.g., hospitals versus long-term care facilities), making generalization of findings potentially problematic. Construction standards for hospitals or other health-care facilities may not apply to residential home-care units. Similarly, infection-control measures indicated for immunosuppressed patient care are usually not necessary in those facilities where such patients are not present.
Other recommendations were derived from knowledge gained during infectious disease investigations in health-care facilities, where successful termination of the outbreak was often the result of multiple interventions, the majority of which cannot be independently and rigorously evaluated. This is especially true for construction situations involving air or water.
Other recommendations were derived from empiric engineering concepts and may reflect industry standards rather than evidence-based conclusions. Where recommendations refer to guidance from the American Institute of Architects (AIA), the statements reflect standards intended for new construction or renovation. Existing structures and engineered systems are expected to be in continued compliance with those standards in effect at the time of construction or renovation.
Also, in the absence of scientific confirmation, certain infection-control recommendations that cannot be rigorously evaluated are based on strong theoretic rationale and suggestive evidence. Finally, certain recommendations are derived from existing federal regulations.
Performance Measurements
Infections caused by the microorganisms described in this guideline are rare events, and the effect of these recommendations on infection rates in a facility may not be readily measurable. Therefore, the following steps to measure performance are suggested to evaluate these recommendations:
1. Document whether infection-control personnel are actively involved in all phases of a health-care facility's demolition, construction, and renovation. Activities should include performing a risk assessment of the necessary types of construction barriers, and daily monitoring and documenting of the presence of negative airflow within the construction zone or renovation area. 2. Monitor and document daily the negative airflow in AII rooms and positive airflow in PE rooms, especially when patients are in these rooms. 3 . Perform assays at least once a month by using standard quantitative methods for endotoxin in water used to reprocess hemodialyzers, and for heterotrophic and mesophilic bacteria in water used to prepare dialysate and for hemodialyzer reprocessing. 4. Evaluate possible environmental sources (e.g., water, laboratory solutions, or reagents) of specimen contamination when nontuberculous mycobacteria (NTM) of unlikely clinical importance are isolated from clinical cultures. If environmental contamination is found, eliminate the probable mechanisms. 5. Document policies to identify and respond to water damage. Such policies should result in either repair and drying of wet structural or porous materials within 72 hours, or removal of the wet material if drying is unlikely within 72 hours.
Updates to Previous Recommendations
Contributors to this report reviewed primarily Englishlanguage manuscripts identified from reference searches using the National Library of Medicine's MEDLINE, bibliographies of published articles, and infection-control textbooks. All the recommendations may not reflect the opinions of all reviewers. This report updates the following published guidelines and recommendations:
CDC. Guideline for handwashing and hospital environmental control. MMWR 1998; 37(No. 24) . Replaces sections on microbiologic sampling, laundry, infective waste, and housekeeping.
Tablan OC, Anderson 
Rationale for Recommendations
As in previous CDC guidelines, each recommendation is categorized on the basis of existing scientific data, theoretic rationale, applicability, and possible economic effect. The recommendations are evidence-based wherever possible. However, certain recommendations are derived from empiric infection-control or engineering principles, theoretic rationale, or from experience gained from events that cannot be readily studied (e.g., floods).
The HICPAC system for categorizing recommendations has been modified to include a category for engineering standards and actions required by state or federal regulations. Guidelines and standards published by the AIA, American Society of Heating, Refrigeration, and Air-Conditioning Engineers (ASHRAE), and the Association for the Advancement of Medical Instrumentation (AAMI) form the basis of certain recommendations. These standards reflect a consensus of expert opinions and extensive consultation with agencies of the U.S. Department of Health and Human Services. Compliance with these standards is usually voluntary. However, state and federal governments often adopt these standards as regulations. For example, the standards from AIA regarding construction and design of new or renovated health-care facilities, have been adopted by reference by >40 states. Certain recommendations have two category ratings (e.g., Categories IA and IC or Categories IB and IC), indicating the recommendation is evidence-based as well as a standard or regulation.
Rating Categories
Recommendations are rated according to the following categories:
Category IA. Strongly recommended for implementation and strongly supported by well-designed experimental, clinical, or epidemiologic studies.
Category IB. Strongly recommended for implementation and supported by certain experimental, clinical, or epidemiologic studies and a strong theoretic rationale. (1, (11) (12) (13) (14) (15) (16) 27) . Category IC (AIA: 7.31.D8) 7. Bag dust-filled filters immediately upon removal to prevent dispersion of dust and fungal spores during transport within the facility (4, 28) . Category IB a. Seal or close the bag containing the discarded filter. b. Discard spent filters as regular solid waste, regardless of the area from which they were removed (28). 8. Remove bird roosts and nests near air intakes to prevent mites and fungal spores from entering the ventilation system (27, 29, 30) . Category IB 9. Prevent dust accumulation by cleaning air-duct grilles in accordance with facility-specific procedures and schedules and when rooms are not occupied by patients (1, (10) (11) (12) (13) (14) (15) (16) Other equations are available that include a constant generating source. However, certain diseases (e.g., infectious tuberculosis) are not likely to be aerosolized at a constant rate. The times given assume perfect mixing of the air within the space (i.e., mixing factor = 1). However, perfect mixing usually does not occur. Removal times will be longer in rooms or areas with imperfect mixing or air stagnation. Caution should be exercised in using this table in such situations. For booths or other local ventilation enclosures, manufacturers' instructions should be consulted.
B. Educate both the construction team and health-care staff in immunocompromised patient-care areas regarding the airborne infection risks associated with construction projects, dispersal of fungal spores during such activities, and methods to control the dissemination of fungal spores (11) (12) (13) (14) (15) (16) 27, 50, (52) (53) (54) (55) (56) . Category IB C. Incorporate mandatory adherence agreements for infection control into construction contracts, with penalties for noncompliance and mechanisms to ensure timely correction of problems (1, 11, (13) (14) (15) (16) 27, 50) . Category IC (AIA: 5.1) D. Establish and maintain surveillance for airborne environmental disease (e.g., aspergillosis) as appropriate during construction, renovation, repair, and demolition activities to ensure the health and safety of immunocompromised patients (27, (57) (58) (59) . Category IB 1. Using active surveillance, monitor for airborne infections in immunocompromised patients (27, 37, 57, 58) . Category IB 2. Periodically review the facility's microbiologic, histopathologic, and postmortem data to identify additional cases (27, 37, 57, 58) . Category IB 3. If cases of aspergillosis or other health-careassociated airborne fungal infections occur, aggressively pursue the diagnosis with tissue biopsies and cultures as feasible (11, (13) (14) (15) (16) 27, 50, (57) (58) (59) . Category IB E. Implement infection-control measures relevant to construction, renovation, maintenance, demolition, and repair (1, 16, 49, 50, 60 (1, 11, (13) (14) (15) (16) 50) . h. Clean work zones and their entrances daily by 1) wet-wiping tools and tool carts before their removal from the work zone; 2) placing mats with tacky surfaces inside the entrance; and 3) covering debris and securing this covering before removing debris from the work zone (1, 11, (13) (14) (15) (16) 50) . i. In patient-care areas, for major repairs that include removal of ceiling tiles and disruption of the space above the false ceiling, use plastic sheets or prefabricated plastic units to contain dust; use a negative pressure system within this enclosure to remove dust; and either pass air through an industrialgrade, portable HEPA filter capable of filtration rates of 300-800 ft 3 /min., or exhaust air directly to the outside (16, 50, 64, 67, 69) . j. Upon completion of the project, clean the work zone according to facility procedures, and install barrier curtains to contain dust and debris before removing rigid barriers (1, 11, (13) (14) (15) (16) (48) (49) (50) . k. Flush the water system to clear sediment from pipes to minimize waterborne microorganism proliferation (1,63). l. Restore appropriate ACH, humidity, and pressure differential; clean or replace air filters; dispose of spent filters (3, 4, 28, 47) . F. Use airborne-particle sampling as a tool to evaluate barrier integrity (3, 70) . Category II G. Commission the HVAC system for newly constructed health-care facilities and renovated spaces before occupancy and use, with emphasis on ensuring proper ventilation for operating rooms, AII rooms, and PE areas (1, (70) (71) (72) (27, 48, 76, 79, 80) . Category IB 4. If no epidemiologic evidence of ongoing transmission exists, continue routine maintenance in the area to prevent health-care-acquired fungal disease (27, 75) . Category IB J. If no epidemiologic evidence exists of ongoing transmission of fungal disease, conduct an environmental assessment to find and eliminate the source (11, (13) (14) (15) (16) 27, 44, (49) (50) (51) 60, 81) . Category IB 1. Collect environmental samples from potential sources of airborne fungal spores, preferably by using a high-volume air sampler rather than settle plates (2, 4, 11, (13) (14) (15) (16) 27, 44, 49, 50, 64, 65, (81) (82) (83) (84) (85) (86) . Category IB 2. If either an environmental source of airborne fungi or an engineering problem with filtration or pressure differentials is identified, promptly perform corrective measures to eliminate the source and route of entry (49, 60) . Category IB 3. Use an EPA-registered antifungal biocide (e.g., copper-8-quinolinolate) for decontaminating structural materials (16, 61, 66, 87 Online know what matters.
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2. Intubate the patient in either the AII room or the operating room; if intubating the patient in the operating room, do not allow the doors to open until 99% of the airborne contaminants are removed (Table 1) (34, 117) . Category IB 3. When anesthetizing a patient with confirmed or suspected TB, place a bacterial filter between the anesthesia circuit and patient's airway to prevent contamination of anesthesia equipment or discharge of tubercle bacilli into the ambient air (130, 132) . Category IB 4. Extubate and allow the patient to recover in an AII room (34, 117) . Category IB 5. If the patient has to be extubated in the operating room, allow adequate time for ACH to clean 99% of airborne particles from the air (Table 1) , because extubation is a cough-producing procedure (34, 117) . Category IB C. Use portable, industrial-grade HEPA filters temporarily for supplemental air cleaning during intubation and extubation for TB patients who require surgery (33, 34, 117) . Category II 1. Position the units appropriately so that all room air passes through the filter; obtain engineering consultation to determine the appropriate placements (34 in the system for >2 (but <24 hrs). 4. Use a thorough flushing of the water system instead of chlorination if a highly chlorineresistant microorganism (e.g., Cryptosporidium spp.) is suspected as the water contaminant. Category II F. Flush and restart equipment and fixtures according to manufacturer's instructions. Category II G. Change the pretreatment filter and disinfect the dialysis water system with an EPA-registered product to prevent colonization of the reverse osmosis membrane and downstream microbial contamination (158) . Category II H. Run water softeners through a regeneration cycle to restore their capacity and function. Category II I. If the facility has a water-holding reservoir or water-storage tank, consult the facility engineer or local health department to determine whether this equipment needs to be drained, disinfected with an EPA-registered product, and refilled. Category II J. Implement facility procedures to manage a sewage system failure or flooding (e.g., arranging with other health-care facilities for temporary transfer of patients or provision of services), and establish communications with the local municipal water utility and the local health department to ensure that advisories are received in a timely manner after release (45, 156 (27, 189, 190) . Category IB B. Implement general strategies for detecting and preventing Legionnaires disease in facilities that do not provide care for severely immunocompromised patients (i.e., facilities that do not have HSCT or solid-organ transplant programs) (see Appendix) (27, 189, 190) . Category IB 1. Establish a surveillance process to detect health-care-associated Legionnaires disease (27, 189, 190) . Category IB 2. Inform health-care personnel (e.g., infection control, physicians, patient-care staff, engineering) regarding the potential for Legionnaires disease to occur and measures to prevent and control health-care-associated legionellosis (166, 191) . Category IB 3. Establish mechanisms to provide clinicians with laboratory tests (e.g., culture, urine antigen, direct fluorescence assay [DFA], and serology) for the diagnosis of Legionnaires disease (27, 189) . Category IB C. Maintain a high index of suspicion for health-careassociated Legionnaires disease, and perform laboratory diagnostic tests for legionellosis on suspected cases, especially in patients at risk who do not require a PE for care (e.g., patients receiving systemic steroids; patients aged >65 years; or patients with chronic underlying disease (e.g., diabetes mellitus, congestive heart failure, or chronic obstructive lung disease) (27, 166, 190, (192) (193) (194) (195) (196) (197) (198) . Category IA D. Periodically review the availability and clinicians' use of laboratory diagnostic tests for Legionnaires disease in the facility; if clinicians' use of the tests on patients with diagnosed or suspected pneumonia is limited, implement measures (e.g., an educational campaign) to enhance clinicians' use of the test(s) (193) . Category IB E. If one case of laboratory-confirmed, health-careassociated Legionnaires disease is identified, or if two or more cases of laboratory-suspected, healthcare-associated Legionnaires disease occur during a 6-month period, certain activities should be initiated (181, 189, 191, 193, 199, 200) . Category IB 1. Report the cases to state and local health departments where required. Category IC (States) 2. If the facility does not treat severely immunocompromised patients, conduct an epidemiologic investigation, including retrospective review of microbiologic, serologic, and postmortem data to look for previously unidentified cases of health-care-associated Legionnaires disease, and begin intensive prospective surveillance for additional cases (27, 181, 189, 191, 193, 199, 200) . Category IB 3. If no evidence of continued health-careassociated transmission exists, continue intensive prospective surveillance for >2 months after the initiation of surveillance (27, 181, 189, 191, 193, 199, 200 B. In the absence of an EPA-registered product for water treatment, add sodium hypochlorite to the water: 1. Maintain a 15-ppm chlorine residual in the water of small hydrotherapy tanks, Hubbard tanks, and tubs (250) . Category II 2. Maintain a 2-5-ppm chlorine residual in the water of whirlpools and whirlpool spas (251) . Category II 3. If the pH of the municipal water is in the basic range (e.g., when chloramine is used as the primary drinking water disinfectant in the community), consult the facility engineer regarding the possible need to adjust the pH of the water to a more acidic level before disinfection, to enhance the biocidal activity of the chlorine (252 (254, (256) (257) (258) . Category IB 2. Dry the internal channels of the reprocessed endoscope or bronchoscope by using a proven method (e.g., 70% alcohol followed by forcedair treatment) to lessen the potential for proliferation of waterborne microorganisms and to help prevent biofilm formation (259) (260) (261) (262) (263) . Category IB B. Use water that meets nationally recognized standards set by the EPA for drinking water (<500 CFU/mL for heterotrophic plate count) for routine dental 
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treatment output water (264) (265) (266) (267) . Category IC (EPA: 40 CFR 1 Part 141, Subpart G) C. Take precautions to prevent waterborne contamination of dental unit water lines and instruments. 1. After each patient, discharge water and air for a minimum of 20-30 seconds from any dental device connected to the dental water system that enters a patient's mouth (e.g., handpieces, ultrasonic scalers, or air/water syringes) (265, 268) . Category II 2. Consult with dental water-line manufacturers to 1) determine suitable methods and equipment to obtain the recommended water quality; and 2) determine appropriate methods for monitoring the water to ensure quality is maintained (265, 269) . Category II 3. Consult with the dental unit manufacturer regarding the need for periodic maintenance of antiretraction mechanisms (268, 269) . Category IB 
RecommendationsEnvironmental Services
I. Cleaning and Disinfecting Strategies for Environmental Surfaces in Patient-Care Areas
Continuing Education
2. Do not use alcohol to disinfect large environmental surfaces (273) . Category II 3. Use barrier protective coverings as appropriate for noncritical surfaces that are 1) touched frequently with gloved hands during the delivery of patient care; 2) likely to become contaminated with blood or body substances; or 3) difficult to clean (e.g., computer keyboards) (265) . Category II E. Keep housekeeping surfaces (e.g., floors, walls, tabletops) visibly clean on a regular basis and clean up spills promptly (279) . Category II 1. Use a one-step process and an EPA-registered hospital detergent/disinfectant designed for general housekeeping purposes in patient-care areas where 1) uncertainty exists as to the nature of the soil on the surfaces (e.g., blood or body fluid contamination versus routine dust or dirt); or 2) uncertainty exists regarding the presence of multidrug resistant organisums on such surfaces (272, 274, 280, 281) . Category II 2. Detergent and water are adequate for cleaning surfaces in nonpatient-care areas (e.g., administrative offices). Category II 3. Clean and disinfect high-touch surfaces (e.g., doorknobs, bed rails, light switches, and surfaces in and around toilets in patients' rooms) on a more frequent schedule than minimal-touch housekeeping surfaces. Category II 4. Clean walls, blinds, and window curtains in patient-care areas when they are visibly dusty or soiled (270, (282) (283) (284) . Category II F. Do not perform disinfectant fogging in patient-care areas (270, 285) . Category IB G. Avoid large-surface cleaning methods that produce mists or aerosols, or disperse dust in patient-care areas (37, 48, 51, 73) . Category IB H. Follow proper procedures for effective uses of mops, cloths, and solutions. Category II 1. Prepare cleaning solutions daily or as needed, and replace with fresh solution frequently according to facility policies and procedures (280, 281) . Category II 2. Change the mop head at the beginning of each day and also as required by facility policy, or after cleaning up large spills of blood or other body substances. Category II 3. Clean mops and cloths after use and allow to dry before reuse; or use single-use, disposable mop heads and cloths (282, (286) (287) (288) . Category II I. After the last surgical procedure of the day or night, wet vacuum or mop operating room floors with a single-use mop and an EPA-registered hospital disinfectant (114) . Category IB J. Do not use mats with tacky surfaces at the entrances to operating rooms or infection-control suites (114) . Category IB K. Use appropriate dusting methods for patient-care areas designated for immunocompromised patients (e.g., HSCT patients) (37, 40, 280) . Category IB 1. Wet-dust horizontal surfaces daily by moistening a cloth with a small amount of an EPAregistered hospital detergent/disinfectant (37, 40, 280) . Category IB 2. Avoid dusting methods that disperse dust (e.g., feather-dusting) (40) . Category IB L. Keep vacuums in good repair and equip vacuums with HEPA filters for use areas with patients at risk (37, 40, 280, 289) . Category IB M. Close the doors of immunocompromised patients' rooms when vacuuming, waxing, or buffing corridor floors to minimize exposure to airborne dust (37, 40, 289) . Category IB N. When performing low-or intermediate-level disinfection of environmental surfaces in nurseries and neonatal units, avoid unnecessary exposure of neonates to disinfectant residues on these surfaces by using EPA-registered germicides in accordance with manufacturers' instructions and safety advisories (271, (290) (291) (292) preferred, but if such products are not available, generic sodium hypochlorite solutions (e.g., household chlorine bleach) may be used. 1. Use a 1:100 dilution (500-615 ppm available chlorine) to decontaminate nonporous surfaces after cleaning a spill of either blood or body fluids in patient-care settings (301, 304) . Category IB 2. If a spill involves large amounts of blood or body fluids, or if a blood or culture spill occurs in the laboratory, use a 1:10 dilution (5,000-6,150 ppm available chlorine) for the first application of germicide before cleaning (279, 301) . Category IB
III. Carpeting and Cloth Furnishings
A. Vacuum carpeting in public areas of health-care facilities and in general patient-care areas regularly with well-maintained equipment designed to minimize dust dispersion (280) . Category II B. Periodically perform a thorough, deep cleaning of carpeting as determined by facility policy by using a method that minimizes the production of aerosols and leaves little or no residue (44) . Category II C. Avoid use of carpeting in high-traffic zones in patient-care areas or where spills are likely (e.g., burn therapy units, operating rooms, laboratories, or intensive care units) (44, 305, 306 (314) . Category IB C. Contract for routine pest control service by a credentialed pest-control specialist who will tailor the application to the needs of a health-care facility (315) . Category II D. Place laboratory specimens (e.g., fixed sputum smears) in covered containers for overnight storage (316, 317 (318, (320) (321) (322) . Category IB 1. Pay close attention to cleaning and disinfection of high-touch surfaces in patient-care areas (e.g., bed rails, carts, charts, bedside commodes, bed rails, doorknobs, or faucet handles) (318, (320) (321) (322) . Category IB 2. Ensure compliance by housekeeping staff with cleaning and disinfection procedures (318, (320) (321) (322) . Category IB 3. Use EPA-registered chemical germicides appropriate for the surface to be disinfected (e.g., either low-or intermediate-level disinfection) as specified by the manufacturer's instructions (271, (322) (323) (324) (325) (326) (327) . Category IB, IC (EPA: 7 USC § 136 et seq.)
4. When contact precautions are indicated for patient care, use disposable patient-care items (e.g., blood pressure cuffs) wherever possible to minimize cross-contamination with multipleresistant microorganisms (328) . Category IB 5. Follow these same surface-cleaning and disinfecting measures for managing the environment of VRSA patients (320) (321) (322) 327) . Category II C. Environmental-surface culturing can be used to verify the efficacy of hospital policies and procedures before and after cleaning and disinfecting rooms that house patients with VRE (318, (329) (330) (331) (332) (333) 
RecommendationsEnvironmental Sampling
I. General Information
A. Do not conduct random, undirected, microbiologic sampling of air, water, and environmental surfaces in health-care facilities (270, 343) . Category IB B. When indicated, conduct microbiologic sampling as part of an epidemiologic investigation or during assessment of hazardous environmental conditions to detect contamination or verify abatement of a hazard (270, 343) . Category IB C. Limit microbiologic sampling for quality assurance purposes to 1) biologic monitoring of sterilization processes; 2) monthly cultures of water and dialysate in hemodialysis units; and 3) short-term evaluation of the impact of infection-control measures or changes in infection-control protocols (270, 343) . Category IB II. Air, Water, and Environmental Surface Sampling A. When conducting any form of environmental sampling, identify existing comparative standards and fully document departures from standard methods (343) (344) (345) (346) (347) . Category II B. Select a high-volume air sampling device if anticipated levels of microbial airborne contamination are expected to be low (345, 346, 348, 349) . Category II C. Do not use settle plates to quantify the concentration of airborne fungal spores (348) . Category II D. When sampling water, choose growth media and incubation conditions that will facilitate recovery of waterborne organisms (344) . Category II E. When using a sample/rinse method for sampling an environmental surface, develop and document a procedure for manipulating the swab, gauze, or sponge in a reproducible manner so that results are comparable (347 (400) . Category IC (DHHS: BMBL) 1. Biosafety level 4 laboratories must inactivate microbiologic wastes in the laboratory by using an approved inactivation method (e.g., autoclaving) before transport to and disposal in a sanitary landfill (400) . Category IC (DHHS: BMBL) 2. Biosafety level 3 laboratories must inactivate microbiologic wastes in the laboratory by using an approved inactivation method (e.g., autoclaving) or incinerate them at the facility before transport to and disposal in a sanitary landfill (400) . Category IC (DHHS: BMBL) C. Biosafety levels 1 and 2 laboratories should develop strategies to inactivate amplified microbial cultures and stocks onsite by using an approved inactivation method (e.g., autoclaving) instead of packaging and shipping untreated wastes to an offsite facility for treatment and disposal (400, (406) (407) (408) (36, 109, 270) . Category II C. Decontaminate bulk blood and body fluids from VHF patients by using approved inactivation methods (e.g., autoclaving or chemical treatment) before disposal (36, 109) . Category IC, II (States) D. When discarding regulated medical waste generated during the routine (i.e., nonsurgical) care of CJD patients, contain these wastes and decontaminate them by using approved inactivation methods (e.g., autoclaving or incineration) appropriate for the medical waste category (e.g., blood, sharps, or pathological waste) (36, 270, 273, 336) . Category IC, II (States) E. Incinerate medical wastes (e.g., central nervous system tissues or contaminated disposable materials) from brain autopsy or biopsy procedures of diagnosed or suspected CJD patients (340, 342) . Category IB Legionella spp. are ubiquitous and can be isolated from 20%-40% of freshwater environments, including man-made water systems (1, 2) . In health-care facilities, where legionellae in potable water rarely result in disease among nonimmunocompromised patients, courses of remedial action are unclear.
Scheduled microbiologic monitoring for legionellae remains controversial because the presence of legionellae is not necessarily evidence of a potential for causing disease (3). CDC recommends aggressive disinfection measures for cleaning and maintaining devices known to transmit legionellae, but does not recommend regularly scheduled microbiologic assays for the bacteria (4). However, scheduled monitoring of potable water within a hospital might be considered in certain settings where persons are highly susceptible to illness and mortality from Legionella infection (e.g., hematopoietic stem cell transplantation units and solid organ transplant units) (5) . Also, after an outbreak of legionellosis, health officials agree monitoring is necessary to identify the source and to evaluate the efficacy of biocides or other prevention measures.
Examination of water samples is the most efficient microbiologic method for identifying sources of legionellae and is an integral part of an epidemiologic investigation into healthcare-associated Legionnaires' disease. Because of the diversity of plumbing and HVAC systems in health-care facilities, the number and types of sites to be tested must be determined before collection of water samples. One environmental sampling protocol that addresses sampling site selection in hospitals might serve as a prototype for sampling in other institutions (6) . Any water source that might be aerosolized should be considered a potential source for transmission of legionellae. The bacteria are rarely found in municipal water supplies and tend to colonize plumbing systems and point-of-use devices. To colonize, legionellae usually require a temperature range of 77 º F-108 º F (25 º C-42.2 º C ) (7) and are most commonly located in hot water systems. Legionellae do not survive drying. Therefore, air-conditioning equipment condensate, which frequently evaporates, is not a likely source (8) .
